Biophytis (EPA:ALBPS) | WebDisclosure

PRESS RELEASE

published on 07/29/2026 at 22:59, 8 days ago

Biophytis annonce la publication de ses comptes annuels 2025 et la reprise de la cotation de son action
Biophytis annonce la publication de ses comptes annuels 2025 et la reprise de la cotation de son action sur Euronext Growth Paris. Les résultats financiers et opérationnels sont présentés ainsi que la situation de trésorerie

Résultats Financiers Euronext Growth Paris Biophytis Trésorerie Comptes Annuels
PRESS RELEASE

published on 07/29/2026 at 22:59, 8 days ago

BIOPHYTIS ANNOUNCES THE AUDITING OF ITS 2025 FINANCIAL STATEMENTS AND THE RESUMPTION OF TRADING IN ITS STOCK
Biophytis announces the auditing of its 2025 financial statements and the resumption of trading in its stock. The company's financial debt and current liabilities decreased by 5% in 2025. Net loss improved by 13% compared to 2024

Financial Statements Biophytis Trading Net Loss Financial Debt
BRIEF

published on 07/01/2026 at 07:05, 1 month 5 days ago

Biophytis : Résultats financiers provisoires 2025 et nouvelles stratégies

Résultats Financiers Biophytis Sarcopénie Continuité D'exploitation Joint-venture Asie
BRIEF

published on 07/01/2026 at 07:05, 1 month 5 days ago

Biophytis Reports 2025 Financial Outcomes and Strategic Plans

Regulatory Milestones Asian Joint Venture Biophytis Financial Results Sarcopenia Clinical Trials Cash Flow Uncertainty
REGULATED PRESS RELEASE

published on 07/01/2026 at 07:00, 1 month 5 days ago

BIOPHYTIS REPORTS ITS PROVISIONAL FINANCIAL RESULTS AND PROVIDES ITS STRATEGIC OUTLOOK
Biophytis reports provisional financial results for fiscal year 2025 and strategic outlook, including milestones in sarcopenia and obesity programs, engagement with scientific community, and financial restructuring

Biophytis Sarcopenia Obesity Strategic Outlook Provisional Financial Results
REGULATED PRESS RELEASE

published on 07/01/2026 at 07:00, 1 month 5 days ago

Biophytis communique ses résultats financiers provisoires et partage ses perspectives stratégiques
Biophytis communique ses résultats financiers provisoires pour l'exercice 2025 et partage ses perspectives stratégiques, incluant des avancées dans la sarcopénie et l'obésité

Résultats Financiers Biophytis Sarcopénie Obésité Perspectives Stratégiques
BRIEF

published on 06/15/2026 at 23:05, 1 month 21 days ago

Biophytis Temporarily Suspends Share Trading

Biophytis Financial Report Euronext Growth Share Suspension Operational Delay
BRIEF

published on 06/15/2026 at 23:05, 1 month 21 days ago

Suspension provisoire de la cotation de Biophytis

Biophytis Actions Euronext Growth Suspension Cotation Retard Rapport Financier
REGULATED PRESS RELEASE

published on 06/15/2026 at 23:00, 1 month 21 days ago

Biophytis annonce la suspension provisoire de la cotation de son action
Biophytis suspend temporairement la cotation de son action sur Euronext en raison d'un retard dans la publication du rapport financier. La reprise est prévue après certification des comptes

Biophytis Rapport Financier Cotation Retard Suspension
REGULATED PRESS RELEASE

published on 06/15/2026 at 23:00, 1 month 21 days ago

BIOPHYTIS ANNOUNCES THE TEMPORARY SUSPENSION OF THE TRADING OF ITS SHARES
Biophytis announces temporary suspension of share trading on Euronext due to delay in financial report, expected to resume by end of July 2026

Biophytis Euronext Financial Report Suspension Share Trading

Published on 08/06/2026 at 22:15, 53 minutes ago

Biomind Labs Announces Listing on the Canadian Securities Exchange and the Delisting From the Cboe Canada
Published on 08/06/2026 at 22:05, 1 hour 3 minutes ago

Innodata Reports Record Second Quarter 2026 Results
Published on 08/06/2026 at 22:00, 1 hour 8 minutes ago

Gold Terra Announces Closing of Second Tranche of the C$10.8M LIFE
Published on 08/06/2026 at 15:00, 8 hours 8 minutes ago

Norsemont Strategically Expands Choquelimpie Land Package To 9,048 Hectares
Published on 08/06/2026 at 14:30, 8 hours 38 minutes ago

Loar Holdings Inc. Reports Q2 2026 Record Results and Upward Revision to 2026 Outlook

View all ACCESSWIRE

Published on 08/06/2026 at 22:50, 18 minutes ago

Amrize Reports Second Quarter 2026 Results
Published on 08/06/2026 at 22:15, 53 minutes ago

BIRKENSTOCK SEEKS TO FILL VACANCY IN THE BOARD OF DIRECTORS WITH AN INDEPENDENT DIRECTOR, FOLLOWING ALEXANDRE ARNAULT'S RESIGNATION DUE TO PROFESSIONAL COMMITTMENTS
Published on 08/06/2026 at 21:45, 1 hour 23 minutes ago

FP Markets Analysis: Japanese Yen at a Crossroads as Markets Weigh Next Move
Published on 08/06/2026 at 19:05, 4 hours 3 minutes ago

Cision Wins 2026 MarTech Breakthrough Awards for Social Listening, Press Release Distribution, and AEO
Published on 08/06/2026 at 18:24, 4 hours 43 minutes ago

EQS-Adhoc: Allgeier SE: Allgeier Increases Revenue by 10 Percent in the First Half of 2026 and Confirms Its Guidance for 2026

View all EQS

Published on 08/06/2026 at 18:26, 4 hours 42 minutes ago

Air Liquide voting rights as of July 31st 2026
Published on 08/06/2026 at 18:26, 4 hours 42 minutes ago

Air Liquide droits de vote au 31 juillet 2026
Published on 08/06/2026 at 17:46, 5 hours 22 minutes ago

Déclaration des droits de vote à fin juillet 2026
Published on 08/06/2026 at 17:45, 5 hours 23 minutes ago

Déclaration des droits de vote à fin juillet 2026
Published on 08/06/2026 at 17:45, 5 hours 23 minutes ago

Declaration of voting rights at the end of July 2026

View all LES ECHOS COMFI WIRE

News